Russell J. Howard
Executive Chairman
Biotechnology
NeuClone
Australia
Biography
Dr Russell Howard joined NeuClone as Executive Chairman in January 2013. As a Senior executive with 15 years of CEO experience leading technology-based Life Science companies, most notably Maxygen Inc (NASDAQ: MAXY), Dr Howard has led corporate development strategies to generate over 30 products marketed worldwide and raised over $250 million on the U.S. public equity market. Dr Howard is also the inventor of a rapid, inexpensive, human malaria diagnostic test marketed worldwide for 17 years. Dr Howard has a breadth of technical experience in product discovery and development for pharmaceuticals and has published over 140 scientific publications in refereed journals and is an inventor on five issued patents. Russell is also non-executive director of Prima Biomed (ASX: PRD).
Research Interest
Life Sciences
